TMCI Treace Medical Concepts, Inc.

$4.18 +4.50%

Healthcare · Surgical & Medical Instruments & Apparatus

Treace Medical Concepts, Inc. (TMCI) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $271 million. Shares last traded at $4.18, 46.3% below their 52-week high. Over the past year the stock is down 23.2%. Net profit margin is -27.7%, below the peer median of -7.6%. Revenue grew 1.6% year over year.

Market Cap

$271M

Shares Out

64.9M

EPS (TTM)

$-1.85

P/E Ratio

—

P/S Ratio

1.27

P/B Ratio

3.51

Dividend / Share

—

Dividend Yield

—

52-Week High

$7.78

52-Week Low

$1.18

Volume

41,458

Avg Vol (3m)

52,313.413

Performance

+6.91%

+54.24%

+219.08%

+55.39%

YTD

+67.20%

-23.16%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

68.23

SMA (50)

$2.67

SMA (200)

$3.40

Price vs SMA50

+56.39%

Price vs SMA200

+22.82%

ATR (14)

$0.32

Financials

Revenue

$213M

Net Income

$-59M

Gross Margin

79.8%

Operating Margin

-25.5%

Net Margin

-27.7%

Return on Equity

-76.4%

Return on Assets

-32.0%

Current Ratio

3.58

Debt / Equity

0.72

Revenue Growth (YoY)

+1.6%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.28	2026-05-08
FY 2025	$-0.93	2026-02-27
Q3 2025	$-0.79	2025-11-06
Q2 2025	$-0.53	2025-08-07
Q1 2026	$-0.25	2026-05-08
FY 2025	$-0.90	2026-02-27

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

TMCI vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

1.27 / 2.52 med

-49% discount

Net margin vs peers

-27.7% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.